Finance

Beta
Lists
CSMYF:OTCMKTS
Cosmos Pharmaceutical Corp
$39.31
0.00%
(0.00) 1D
May 13, 9:30:52 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CSMYF...
Mkt. cap
481.37B
Avg. vol.
12.00
Volume
0.00
52-wk high
$61.39
52-wk low
$39.31
Beta
0.20
Shares outstanding
80.00M
No. of employees
6K
News stories
From sources across the web
About Cosmos Pharmaceutical Corp
CEO-
Employees5.71K
FoundedDec 1983
Headquarters-
SectorDrug
Websitecosmospc.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
May 2025
Aug 2025
Nov 2025
Feb 2026
Revenue
259.12B
272.39B
264.78B
273.20B
Cost of goods sold
205.05B
215.22B
209.07B
216.15B
Cost of revenue
205.05B
215.22B
209.07B
216.15B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
24.51B
45.64B
46.57B
45.83B
Operating expense
44.95B
45.64B
46.57B
45.83B
Total operating expenses
250.00B
260.86B
255.64B
261.97B
Operating income
9.12B
11.54B
9.14B
11.23B
Other non operating income
743.00M
627.00M
801.00M
667.00M
EBT including unusual items
9.19B
12.09B
9.58B
11.96B
EBT excluding unusual items
9.77B
12.08B
9.85B
11.81B
Income tax expense
551.00M
3.92B
3.10B
3.86B
Effective tax rate
6.00%
32.40%
32.35%
32.26%
Other operating expenses
-
-
-
-
Net income
8.64B
8.17B
6.48B
8.10B
Net profit margin
3.33%
3.00%
2.45%
2.96%
Earnings per share
-
-
-
-
Interest and investment income
12.00M
27.00M
19.00M
16.00M
Interest expense
-109.00M
-110.00M
-107.00M
-107.00M
Net interest expenses
-97.00M
-83.00M
-88.00M
-91.00M
Depreciation and amortization charges
20.45B
-
-
-
EBITDA
14.68B
17.09B
15.00B
16.79B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer